OPEN Research Support
head

Physician
Maja Hellfritzsch Poulsen
Department of Clinical Pharmacology, Odense University Hospital


Project management
Project status    Closed
 
Data collection dates
Start 01.01.2016  
End 01.06.2016  
 



Switching and side-effects among users of oral anticoagulants: a pharmacy-based interview study

Short summary

The aim of this study is to increase the knowledge of aspects of oral anticoagulant therapy not obtainable from registries.

The study is based on structured interviews. Informants comprise users of oral anticoagulants consecutively recruited at two Danish community pharmacies. Interviews with patients filling an oral anticoagulant at a community pharmacy are performed by the dispensing pharmacist or pharmaconomist. Information collected concern the patient, specifics of the current anticoagulant treatment, prior switching of anticoagulant treatment, and adverse effects of the treatment.


Rationale

In a community-based population of oral anticoagulant users we will:

  • obtain detailed knowledge of switching between oral anticoagulants including types of switches as well as promoter and reasons for switching.
  • describe adverse effects of oral anticoagulants both in terms of specific side effects as well as limitations in everyday life. 


Description of the cohort

The study population comprises of patients filling an oral anticoagulant for their own use within normal opening hours at one of two study pharmacies in the period march 18th, 2016 - May 31st, 2016.


Data and biological material

A questionnaire specifically designed for the purpose of this study is used. The dispensing pharmacist/pharmaconomists has been instructed to ask the questions one by one and to enter the information into the questionnaire during the interview. Information comprise the CPR-number of the patient, type of OAC, indication for OAC treatment, if the patient have used other OACs within the last two years, and if so, why OAC treatment have been switched. All prevalent users are asked if they in any way considered their OAC treatment as a limitation. Further, patients filling a prescription for a NOAC are asked if they have experienced side-effects of their current treatment, and if so, which specific side-effects. 


Collaborating researchers and departments

Department of Clinical Pharmacology, Odense University Hospital

  • PhD-student Maja Hellfritzsch, MD
  • Postdoc and Pharmacist Anton Pottegård, PhD

Sønderbro pharmacy

  • Pharmacist Susanne Bendixen

Marselisborg pharmacy

  • Pharmacist Mikkel Nørreslet